Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Published on by Top Pharmaceutical

Nazia chaudhary | Drug Repurposing | Young Scientist Award

Dr Nazia chaudhary, ACTREC, TMC, India

Dr. Nazia Chaudhary is a distinguished cancer researcher 🧬 with a Ph.D. focused on pathways promoting tumorigenesis and therapy resistance upon Plakophilin 3 loss 🎗️. Her academic journey includes notable projects on protease-producing thermophiles 🌡️ and mitochondrial function ⚡. She co-holds patents on Lipocalin-2 antibodies 🧪 and has published extensively in high-impact journals 📚, including Redox Biology and FEBS Letters. A DST Inspire Faculty Fellow (2023) 🌟, she has received numerous awards, including the Vaishno Endowment Prize 🏆 and Mahindra Talent Scholarships 🎓. Dr. Chaudhary’s impactful work has been presented globally 🌍, including at Cold Spring Harbor Laboratory, New York.

Publication Profile

Orcid

Academic Project

Dr. Nazia Chaudhary is an accomplished researcher with a Ph.D. focused on the project “Characterization of pathways that promote tumorigenesis, radio, and chemo-resistance upon Plakophilin 3 loss.” 💡🧬 She worked on isolating and characterizing protease and antimicrobial-producing thermophiles from Ganeshpuri hot springs at St. Xavier’s College, Mumbai (Jan-Apr 2015). 🌋🔬 Additionally, she contributed to the external project “MKT1 Dependent Regulation of Mitochondrial Function” at Tata Institute of Fundamental Research (May-Aug 2014). 🧪⚙️ Her EXSP project involved isolating and screening thermophilic Actinomycetes for enzymes with industrial importance. 🔍🌡️ Dr. Chaudhary’s diverse research showcases her expertise in microbiology and biotechnology. 🌟

Conference Attended

Dr. Nazia Chaudhary has showcased her research on various esteemed platforms. She presented a poster titled “Screening of Thermophilic Actinomycetes Capable of Producing Enzymes of Industrial Importance” at the Shri Sajjan Gupta Memorial Trophy for Excellence in Biological Science, held on December 11, 2012, at G.N. Khalsa College. Another poster, “Increase in Lipocalin2 Expression Upon Plakophilin3 Loss Confers Chemo and Radioresistance to Tumor Cells,” was presented at the Environmental Mutagen Society of India (EMSI) conference in January 2018 at BARC, Mumbai, and at the prestigious Mechanisms & Models of Cancer meeting in August 2018 at Cold Spring Harbor Laboratory, New York. 🌟🔬📊

Awards and Honors

Dr. Nazia Chaudhary is a distinguished scholar with multiple accolades. She was awarded the prestigious DST Inspire Faculty Award in 2023 and recognized for her research on lipocalin 2 expression and chemo-radiotherapy resistance at the 14th Indo-Australian Biotechnology Conference. She served as a Board of Studies member for Sophia College’s Zoology Department (2018-2021). Throughout her academic journey, she earned various honors, including the Ramidevi Murlidhar Jalan Award 🏆, Saifee Education Aid Scholarship 🎓, and the Mahindra Search for Talent Scholarship 🌟. Her exceptional performance also earned her the Mrs. A. Varghese Prize 🥇 and several other prestigious scholarships and awards.

Patent

Dr. Nazia Chaudhary, along with Sorab N. Dalal, Manjula Das, Sujan K. Dhar, and Smitha P. K., contributed to the development of “Antibodies Against Lipocalin-2 and Use Thereof.” This groundbreaking research led to two key milestones. The first was the PCT application (PCT/IN2020/051068) with publication no. WO/2021/137254 on July 8, 2021. The second was the Indian patent (DBT Indian Patent no: 202021000274) granted on July 30, 2021, published in the Patent Office journal no. 31/2021. These innovations hold significant potential for medical advancements. 🧬💉🧪🔬

Research Focus

Dr. Nazia Chaudhary’s research focuses on the molecular mechanisms of cancer progression, therapy resistance, and invasion, particularly in triple-negative breast cancer (TNBC) and colorectal cancer. She investigates the role of Lipocalin 2 (LCN2) in regulating cellular processes like focal adhesion formation, actin glutathionylation, and ferroptosis inhibition, which are critical for tumor cell migration and resistance to treatment. Her work explores the interplay between signaling pathways, such as Src activation and glutathione metabolism, to uncover potential vulnerabilities in cancer cells. 🧬💥💉🧪🧫

Publication Top Notes

LCN2 promotes focal adhesion formation and invasion by stimulating Src activation

EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI

GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition

Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration.

The Role of Lipocalin 2 (LCN2) in Regulating Ferroptosis and Therapy Resistance

Ajaz Ahmad| Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Ajaz Ahmad | Drug Delivery Systems| Best Researcher Award

 King Saud University, Saudi Arabia

Author Profile

🎓Early Academic Pursuits 

Professor Ajaz Ahmad began his distinguished academic journey at the prestigious Hamdard University in New Delhi, India. He earned a Bachelor of Pharmacy (B.Pharm) in 2005, where he demonstrated an early inclination toward pharmaceutical sciences. Continuing his education at the same institution, he completed a Master of Pharmacy (M.Pharm) in 2007, refining his focus on drug delivery and molecular pharmacology. Driven by a passion for research, he pursued a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, which he completed in 2011. His doctoral research laid the foundation for his expertise in drug discovery, pharmacokinetics, and the molecular mechanisms underpinning drug actions.

💼Professional Endeavors 

King Saud University, Saudi Arabia
Prof. Ahmad joined the College of Pharmacy at King Saud University in 2011 as an Assistant Professor in Clinical Pharmacy. Over the next decade, his contributions to research and teaching led to successive promotions—first as an Associate Professor in 2017 and then to his current role as Professor in Clinical Pharmacy in January 2024. At King Saud University, Prof. Ahmad’s role encompasses teaching advanced courses, mentoring postgraduate students, and conducting cutting-edge research in pharmacology and drug development.International Collaborations
Since 2015, Prof. Ahmad has served as a research collaborator with the Mayo Clinic, USA, a testament to his global reputation in pharmaceutical sciences. In 2013, he was appointed an Honorary Research Associate at the University of Hong Kong, further broadening his academic and professional network.Patents and Industry EngagementProf. Ahmad holds a U.S. patent (US20170231925A1) for treating neurovascular complications of diabetes mellitus. This innovation highlights his commitment to bridging the gap between research and practical healthcare applications.

🔬Contributions and Research Focus 

Prof. Ahmad’s research covers a broad spectrum of topics in pharmaceutical sciences, with particular focus areas including:Preclinical Drug Development: He has explored novel therapeutic agents, focusing on their efficacy, safety, and molecular mechanisms.Pharmacokinetics and Drug Metabolism: His work delves into the ADME (absorption, distribution, metabolism, and excretion) properties of drugs, optimizing formulations and dosing regimens.Bioanalytical Method Development: Prof. Ahmad designs and validates analytical methods for drug quantification, ensuring reproducibility and precision.Animal Models for Disease Research: He conducts in vivo studies simulating human diseases like cancer, diabetes, and cardiovascular disorders, with a focus on ethical handling and translational applications.Sepsis Research: Investigating biomarkers for early diagnosis and developing therapeutic strategies to combat sepsis.Vascular Pharmacology: Using myography techniques, he explores interventions for vascular diseases and evaluates novel therapeutic targets.

📖Notable Publications

Molecular insights into anti-Protozoal action of natural compounds against
  • Authors : Raish M; Ahmad A; MOHD SHAHNAWAZ KHAN; Kalam MA
  • Journal: biomolecular structure & dynamics
  • Year: 2023
A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA
  • Authors : Mudassar Shahid; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N et al.
  • Journal: Pharmaceutical Society
  • Year: 2023
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling.
  • Authors : Ahmad Ansari M; Shahid M; Ahmad SF; Ahmad A; Alanazi A; Malik A; Bin Jardan YA; Attia SM; Bakheet SA; Raish M
  • Journal: Pharmaceutical Sciences
  • Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
  • Authors : Zhang, M., Si, S.J., Dai, W.J., … Jin, F., Jiang, L.Q.
  • Journal: Pharmaceutical Society
  • Year: 2023
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
  • Authors : Mohammad raish; Ahmad A; Mudassar Shahid; Yousef A Bin Jardan; Abdul Ahad; Dr Mohd Abul Kalam; Mushtaq Ahmad Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:Molecules
  • Year: 2023

Dr. Rahul Reddy|Pharmacology|Excellence in Research

Published on by Top Pharmaceutical

Dr.RahulReddy|Pharmacology|Excellence in Research

Dr. Rahul Reddy at Lautoka Hospital ,Fiji

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Rahul Krishna Reddy, a passionate medical professional, laid the foundation of his academic journey at Lautoka Andhra Sangam Primary School, where he studied from 2000 to 2008. He then progressed to Natabua High School (2009–2013), excelling academically and developing a keen interest in the medical sciences. His educational journey gained international momentum when he pursued a Chinese language program (HSK Level 4) at Shandong University in 2013–2014. This preparatory phase was instrumental in equipping him with linguistic skills for his future studies in China.

Rahul enrolled at Dalian Medical University (2014–2019), where he earned his MBBS degree. His time at Dalian was marked by rigorous academic training and multiple internships, including at the First Affiliated Hospital of Dalian Medical University. This exposure to advanced medical systems honed his clinical skills and solidified his career in surgery and medicine.

Professional Endeavors 🩺

Rahul’s professional journey is a testament to his dedication and commitment to the healthcare field. His initial post-MBBS years were spent at renowned institutions, including the Colonial War Memorial Hospital and Lautoka Hospital, where he completed intensive internship programs (2019–2021). These internships provided him with hands-on experience in diverse medical and surgical disciplines.

From 2021 to 2022, he played a crucial role in Fiji’s fight against COVID-19 as part of the Nadroga/Navosa COVID Team, showcasing his adaptability and resilience in public health crises. Later, as a Medical Officer at Vatukarasa Health Center (2022–2023), Rahul delivered primary care services, demonstrating his ability to cater to the diverse medical needs of his community. Currently, he serves as a Surgical Registrar at Lautoka Hospital, focusing on complex surgical cases and contributing significantly to patient outcomes.

Contributions and Research Focus 🔬

Rahul has made significant strides in clinical research, focusing on improving healthcare outcomes in Fiji. His studies have explored critical areas such as burn injuries, appendicitis, and innovative surgical techniques. Notable publications include:

  • Burns Injury Characteristics and Outcomes at Lautoka Hospital, highlighting critical insights into managing burn patients in resource-limited settings.
  • Research on acute appendicitis outcomes, offering data-driven recommendations for improving surgical care in Fiji.
  • Pioneering work on laparoscopic radical prostatectomy, reflecting his interest in minimally invasive surgery.
  • Contributions to the understanding of rare cases like primary epithelioid hemangioendothelioma and seminal vesicle cystadenoma through internationally recognized publications.

Rahul’s commitment to research and evidence-based practice demonstrates his dedication to advancing medical science in the Pacific region.

Accolades and Recognition 🏆

Rahul’s work has been recognized both nationally and internationally. In 2024, he won the Outstanding Young Investigator Award at the Fiji Medical Association Research Conference. His impactful presentations at conferences, including the Diabetic Foot Symposium and the Pacific Islands Health Research Symposium, have established him as a thought leader in surgical and public health topics.

Rahul has also actively participated in workshops, such as the EMSB and Pain Management sessions, further enhancing his clinical expertise. His continued professional development reflects his commitment to lifelong learning.

Impact and Influence 🌏

Rahul’s influence extends beyond the operating room. As a healthcare provider in Fiji, he has been instrumental in improving patient care and mentoring junior medical staff. His research contributions address key regional healthcare challenges, ensuring evidence-based practices are integrated into daily medical routines.

During the COVID-19 pandemic, his involvement in the Nadroga/Navosa COVID Team was pivotal in managing the outbreak, reflecting his leadership skills and community dedication.

Legacy and Future Contributions 🚀

Rahul Krishna Reddy is poised to leave a lasting legacy in the medical field. His combination of clinical expertise, research acumen, and community service positions him as a trailblazer in Fijian healthcare. Looking ahead, Rahul envisions expanding his contributions to global medical research, particularly in surgical innovation and healthcare systems in resource-limited settings.

His unwavering dedication to improving healthcare outcomes and fostering medical education ensures his enduring impact. As he continues to grow professionally, Rahul exemplifies the values of compassion, innovation, and excellence in medicine.

Conclusion 🌟

From his early academic achievements to his current role as a Surgical Registrar, Rahul Krishna Reddy’s journey reflects an unwavering commitment to healthcare. His research and clinical endeavors are paving the way for improved medical practices in Fiji and beyond. Rahul’s accomplishments and aspirations set a high standard for the next generation of medical professionals, cementing his position as a leader in the field.

🎓Publication 

Laparoscopic excision of seminal vesicle cystadenoma

  • Authors   : Qi Zhen Tang, Zhong Lin, Rahul Krishna Reddy, Zhi Wei Zhang
  • Journal    : Urology Case Reports
  • Year         :2019

Burns injury characteristics and outcomes at lautoka hospital, fiji

      • Authors   : Rahul Krishna Reddy, Arun Murari, Akhtar Ali, Ronal Kumar, Livai Lutunaika, Abhay Choudhari, Swastika Devi, Famiza Kulsum
      • Journal    : Burns Open
      • Year         :2024

Characteristics and Outcomes of Acute Appendicitis in Lautoka Aspen Hospital, Fiji: An Observational Retrospective Study

  • Authors   : Rahul Krishna Reddy, M Arun, K Ronal, Akhtar Ali, Livai Lutunaika, Y Devi Chandra
  • Journal    : World J Surg Surgical Res
  • Year         :2024

Primary Epithelioid Hemangioendothelioma of the Kidney Pelvis

  • Authors   :Rahul Reddy
  • Journal     : American Journal of Surgery and Clinical Case Reports
  • Year         :2020                                                                                                                                                                                                                                                 

Dr. Michel Fares|Drug analysis|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Michel Fares|Drug analysis|Best Researcher Award

Dr. Michel Fares at Nahda University,Egypt

PROFILE  

scopus

Orcid

Google scholar

 

 

Early Academic Pursuits 📚

Michel Yousry Fares embarked on his academic journey with a strong foundation in pharmaceutical sciences, receiving his Bachelor of Pharmacy degree from Nahda University in Beni Suef, Egypt, in 2013. Graduating with honors and a high GPA of 3.89, he demonstrated an early commitment to excellence in his field. His passion for analytical chemistry led him to pursue a Master’s degree in Pharmaceutical Analytical Chemistry at Beni Suef University, where he further honed his skills and knowledge. In 2022, Michel earned his Ph.D. in Pharmaceutical Analytical Chemistry from Cairo University, solidifying his expertise in the analytical methods used to assess pharmaceutical compounds.

Professional Endeavors 🏫

Currently, Michel serves as a Lecturer in the Pharmaceutical Analytical Chemistry Department at Nahda University’s Faculty of Pharmacy, a position he has held since 2022. In this role, he teaches a variety of undergraduate courses, including Pharmaceutical Analytical Chemistry, Instrumental Analysis, and Quality Control of Pharmaceuticals. His responsibilities also extend to research activities in the field of analytical chemistry, where he contributes to advancing the understanding and application of various analytical techniques, such as chromatography and spectroscopy. Michel also plays a key role in mentoring and advising students, helping shape the future of aspiring pharmaceutical professionals.

Beyond his teaching responsibilities, Michel serves as the Vice President of Electronic Learning Support (ELS) at Nahda University, where he has been instrumental in developing and maintaining the university’s e-learning platform, Moodle. His efforts in training instructors and resolving technical issues have significantly enhanced the educational experience for both faculty and students at the university.

Contributions and Research Focus 🔬

Michel’s primary research interests lie in the field of pharmaceutical analytical chemistry, with a specific focus on drug analysis, bioanalysis, and the development of innovative analytical techniques. He has authored several research articles and reviews, including a prominent piece on miniaturized solid-phase extraction techniques for analyzing various pollutants. This work highlights his commitment to advancing analytical methods for environmental and pharmaceutical applications.

His research endeavors also extend to the study of pharmacokinetic parameters, quality assurance, and experimental design. By applying a range of analytical techniques, Michel contributes to improving the quality and safety of pharmaceutical products. His focus on practical applications of pharmaceutical analysis aims to bridge the gap between theoretical knowledge and real-world problem-solving in the pharmaceutical industry.

Accolades and Recognition 🏅

Michel’s contributions to both research and education have not gone unnoticed. He was honored with the “Best Research Publishing Record in the Teaching Assistant Category” in 2022 at Nahda University, a testament to his dedication to advancing scientific knowledge. In 2021, he received the “Best Scientific Research in the Field of Applied Pharmaceutical Sciences” award from ACDIMA (The Arab Company for Drug Industries and Medical Appliances), further cementing his reputation as a leading figure in his field.

Michel’s contributions extend beyond the classroom and laboratory, as he has been actively involved in organizing and participating in scientific conferences. Notably, he was a key participant in the 3rd International Conference of the Faculty of Pharmacy at Ain Shams University and the 2nd International Conference of Pharmaceutical & Therapeutical Science in 2023, where he presented on topics such as online education and creativity in analytical chemistry.

Impact and Influence 🌍

Through his work in both academia and research, Michel has had a profound impact on the field of pharmaceutical sciences. His innovative research has contributed to the development of more efficient and accurate analytical methods, particularly in drug analysis and bioanalysis. As a teacher, he has shaped the careers of many future pharmacists and analytical chemists, emphasizing the importance of precision and quality in pharmaceutical testing.

Michel’s influence extends beyond his direct teaching and research contributions. He has been a reviewer for several prestigious scientific journals, including TrAC Trends in Analytical Chemistry and Journal of Pharmaceutical and Biomedical Analysis, where his expertise helps shape the direction of future research in the field.

Legacy and Future Contributions 🌱

Michel’s legacy is one of dedication to the advancement of pharmaceutical sciences and the education of the next generation of professionals. His work in the development of analytical techniques has had a lasting impact on both the academic and pharmaceutical industries, and his commitment to improving the quality of education will continue to benefit students for years to come.

Looking forward, Michel plans to continue his research into novel analytical methods, with a focus on environmental applications and the use of cutting-edge technologies like electrochemistry and chromatography. His goal is to contribute to the development of sustainable practices within pharmaceutical analysis, ensuring that future generations of scientists have the tools they need to meet the evolving challenges of the global pharmaceutical industry.

In addition to his research, Michel is committed to furthering his role in educational leadership, particularly in the integration of digital technologies into the learning process. He envisions a future where e-learning systems are more widely adopted, creating a more accessible and flexible learning environment for students around the world.

Conclusion ✨

Michel Yousry Fares stands out as a dedicated educator, researcher, and leader in the field of pharmaceutical analytical chemistry. His career is characterized by his commitment to excellence in both teaching and research, his impact on the development of analytical methods, and his dedication to shaping the future of pharmaceutical sciences. Through his ongoing work, Michel will continue to leave a positive and lasting legacy in the field, inspiring future generations of scientists and educators.

🎓Publication 

Green analytical chemistry as an integral part of sustainable education development

  • Authors   : Justyna Płotka-Wasylka, Heba M Mohamed, Aleksandra Kurowska-Susdorf, Rajkumar Dewani, Michel Y Fares, Vasil Andruch
  • Journal    :Current Opinion in Green and Sustainable Chemistry
  • Year         :2021

Determination of the abused intravenously self-administered madness drops (Tropicamide) by liquid chromatography in rat plasma; an application to pharmacokinetic study and …

  • Authors   : Maha M Abdelrahman, Nada S Abdelwahab, Maha A Hegazy, Michel Y Fares, Ghada M EL-Sayed
  • Journal    : Microchemical Journal
  • Year         :2020

Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic study

  • Authors   :Michel Y Fares, Nada S Abdelwahab, Maha M Abdelrahman, Hamdy M Abdel-Rahman
  • Journal    : Bioanalysis
  • Year         :2019

Miniaturized solid phase extraction techniques for different kind of pollutants analysis: state of the art and future perspectives–PART 1

  • Authors   : Justyna Płotka-Wasylka, Natalia Jatkowska, Monika Paszkiewicz, Magda Caban, Michel Y Fares, Aysegul Dogan, Salvador Garrigues, Natalia Manousi, Natasa Kalogiouri, Paweł Mateusz Nowak, Victoria F Samanidou, Miguel de la Guardia
  • Journal    :TrAC Trends in Analytical Chemistry
  • Year         :2023

Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study

  • Authors   : Michel Y Fares, Maha A Hegazy, Ghada M El-Sayed, Maha M Abdelrahman, Nada S Abdelwahab
  • Journal    :RSC advances
  • Year         :2022

Mr. Yeniewa Anagaw| Pharmacy|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Yeniewa Anagaw| Pharmaceutical Pharmacy
|Best Researcher Award

Mr. Yeniewa Anagaw at Medical University of Gondar,Ethiopia

PROFILE  

scopus

Google scholar

Early Academic Pursuits 📚

Yeniewa Kerie Anagaw’s journey in academia began with his Bachelor of Pharmacy degree from Miza-Tepi University, Ethiopia, in 2016. Graduating with a commendable cGPA of 3.39/4.00, his directed study explored a critical area of public health, specifically focusing on tuberculosis treatment outcomes and predictors among HIV patients in Southwest Ethiopia. This early research demonstrated his keen interest in addressing significant health challenges affecting his community. He continued his academic growth with a Master of Science in Pharmaceutical Analysis and Quality Assurance at Addis Ababa University, where he earned an impressive cGPA of 3.81/4.00. His thesis, titled “Analytical Method Development and Validation Based on Paper Analytical Device (PAD) for Adulteration Detection in Teff Injera (Ethiopian flatbread),” highlights his dedication to innovation in pharmaceutical analysis and public health. This work, which employed Microwave Plasma Atomic Emission Spectroscopy (MP-AES), underscores his analytical and scientific rigor.

Professional Endeavors and Teaching Commitments 👨‍🏫

Yeniewa’s professional career took off in December 2016 when he joined Finote Selam General Hospital as a junior pharmacist. In this role, he participated in ward rounds and patient chart reviews, where he helped identify, prevent, and mitigate drug-related problems. His responsibilities included ensuring appropriate drug selection and dosage, managing adverse drug reactions, addressing drug interactions, and preparing compounded dermatological formulations. Yeniewa also worked as a pharmacy coordinator, showcasing his leadership and organizational skills early in his career.

By January 2018, Yeniewa transitioned into academia as an assistant lecturer at the University of Gondar’s School of Pharmacy. In this role, he supervised and instructed undergraduate students in Pharmaceutical Analysis laboratory sessions, focusing on hands-on training in instrumental analysis and data interpretation. His role expanded to delivering lectures in Pharmaceutical Analysis, Pharmacy Practice, and Quality Control and Assurance. Yeniewa’s dynamic teaching style, coupled with his passion for research, has made him a pivotal figure in shaping future pharmacists.

Since April 2022, Yeniewa has held a lecturer position at the University of Gondar. Here, his responsibilities have evolved to include not only lecture preparation and delivery but also student mentoring, exam evaluation, and practical learning experiences. Yeniewa’s teaching covers Electroanalytical Methods, IR Spectroscopy, NMR, HPLC, and Mass Spectrometry (MS), which are crucial tools in the field of pharmaceutical science. His ability to guide students through both theoretical and practical knowledge demonstrates his comprehensive approach to education.

Contributions and Research Focus 🔬

Yeniewa’s research interests span across various domains within pharmaceutical sciences, including pharmaceutical analysis, quality assurance, proteomics, metabolomics, drug delivery, and biomarker discovery. His dedication to research is reflected in his published works and his involvement in grant writing for school projects. Yeniewa is particularly passionate about developing analytical methods for drug adulteration detection, exemplified by his thesis on detecting adulterants in Teff Injera. This research is crucial for ensuring food safety and protecting public health.

Additionally, Yeniewa has participated in several community service initiatives. One notable contribution involved the quantitative analysis of table salt used for wound cleaning, showcasing his commitment to improving healthcare practices in Ethiopia. His engagement in such community-oriented projects demonstrates his desire to translate academic research into practical solutions that benefit society.

Accolades and Recognition 🏅

Throughout his career, Yeniewa has earned various certificates and recognition for his contributions to both academia and the pharmaceutical field. Some of his notable achievements include:

  • Certificate of the training workshop on “Anticancer Medicines Quality Evaluation Using the Chemo-spot System.”
  • BMJ Open Reviewer’s Certificate and Peer Reviewer Verification Certificates from Springer Nature, which highlight his contributions to scientific literature through peer review.
  • Presenter Certificate at the “42nd Annual Scientific Conference of the Ethiopia Pharmacy Association (EPA),” where he shared his research with a broader scientific community.
  • Certificates for attending workshops and training sessions on research enhancement, intellectual property, and good manufacturing practices (GMP), indicating his commitment to continuous professional development.

Impact and Influence 🌍

Yeniewa’s influence extends beyond his immediate academic and professional circles. His research on tuberculosis treatment and pharmaceutical adulteration contributes to public health advancements, particularly in Ethiopia. By addressing key issues in drug safety and treatment optimization, he has played a role in enhancing healthcare outcomes for vulnerable populations. As a lecturer, Yeniewa has directly impacted the education of future pharmacists, providing them with the knowledge and skills necessary to excel in both clinical and research settings. His involvement in grant writing and school projects also demonstrates his efforts to foster research initiatives that could have far-reaching benefits.

Legacy and Future Contributions 🌟

As Yeniewa continues his career, his focus remains on bridging the gap between pharmaceutical research and practical healthcare solutions. His expertise in proteomics, drug discovery, and spectroscopic methods positions him as a valuable contributor to ongoing efforts in pharmaceutical innovation. Furthermore, his dedication to teaching ensures that future generations of pharmacists are well-equipped to tackle emerging challenges in the field.

Yeniewa’s future contributions are likely to leave a lasting legacy, both in terms of academic excellence and practical healthcare improvements. His adaptability, hard work, and passion for both teaching and research will continue to drive his success as he navigates the evolving landscape of pharmaceutical sciences.

🎓Publication 

Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia

  • Authors   :Adane Teshome Kefale, Yeniewa Kerie Anagaw
  • Journal    :International Journal of General Medicine
  • Year         :2017

Assessment of community pharmacy professionals’ willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study

  • Authors   : Wondim Ayenew, Abdulwase Mohammed Seid, Asmamaw Emagn Kasahun, Asrat Elias Ergena, Derso Teju Geremaw, Liknaw Workie Limenh, Teshome Bitew Demelash, Wudneh Simegn, Yeniewa Kerie Anagaw, L.
  • Journal    :BMC Health Services Research
  • Year         :2022

Assessment of Knowledge, Attitudes, and Practices of Traditional Healers toward Dosage Forms and Routes of Administration: A Cross‐Sectional Study in Ethiopia

  • Authors   : Liknaw Workie Limenh, Derso Teju Geremew, Asmamaw Emagn Kasahun, Yeniewa Kerie Anagaw, Minichil Chanie Worku, Wudneh Simegn, Wondim Ayenew
  • Journal    :Evidence‐Based Complementary and Alternative Medicine
  • Year         :2023

Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia

  • Authors   :Minichil Chanie Worku, Melese Legesse Mitku, Wondm Ayenew, Liknew Workie Limenh, Asrat Elias Ergena, Derso Teju Geremew, Gizachew Kassahun Bizuneh, Bereket Bahiru Tefera, Biset Asrade Mekonnen, Yeniewa Kerie Anagaw
  • Journal    :Currents in Pharmacy Teaching and Learning
  • Year         :2024

Prevalence and predictors of self-medication with antibiotics in Ethiopia: a systematic review and meta-analysis

  • Authors   :Wondim Ayenew, Tewodros Ayalew Tessema, Yeniewa Kerie Anagaw, Ebrahim Abdela Siraj, Segenet Zewdie, Wudneh Simegn, Liknaw Workie Limenh, Chernet Tafere, Ashagrachew Tewabe Yayehrad
  • Journal    :Antimicrobial Resistance & Infection Control
  • Year         :2024

Prof. Maysoon Al-Haideri| Drug Discovery |Best Researcher Award

Published on by Top Pharmaceutical

Prof. Maysoon Al-Haideri|Drug Discovery|Best Researcher Award

Prof. Maysoon Al-Haideri at University oh Kurdistan Hewlêr,Iraq

PROFILE  

scopus 

 

Early Academic Pursuits 🎓

Dr. Al-Haideri began her educational journey at Baghdad University, where she completed her B.Sc. in Pharmacy in 1973. She demonstrated early promise and a strong interest in clinical analysis, leading her to pursue an Advanced Diploma in Clinical Analysis from Baghdad University between 1977 and 1979. Her academic curiosity and pursuit of excellence took her to the United States, where she attended Columbia University in the City of New York, earning a Master of Arts (M.A.) in 1983, followed by an M.Phil. in Pathology in 1985. Her dedication and passion culminated in a Ph.D. in Pathology from Columbia University in 1987, marking the beginning of an illustrious career in clinical research and academia.

Professional Endeavors 🩺

Dr. Al-Haideri’s professional career began in Iraq, where she gained practical experience and took on leadership roles in several medical institutions. She completed a traineeship in Clinical Hematology, Clinical Biochemistry, Medical Microbiology, Parasitology, and Infectious Diseases at the Ministry of Health in Baghdad from 1974 to 1975. Following this, she served as the Director of the Clinical Laboratory at Abo-Alkhaseab Hospital in Basrah (1975-1976) and Chief of the Clinical Biochemistry and Hematology Divisions at Al-Khadmia Teaching Hospital in Baghdad (1976-1981). During this time, she was also responsible for student supervision and training, highlighting her commitment to fostering the next generation of healthcare professionals.

From 1981 to 1982, Dr. Al-Haideri took on a national role as the Director of Quality Control and Standardization for all public clinical laboratories in Iraq, ensuring the consistent application of best practices in clinical analysis. Her leadership and expertise were further recognized when she undertook a traineeship in infertility at the Ministry of Health in Baghdad in 1982, signaling her growing influence in medical diagnostics and reproductive health.

In the United States, Dr. Al-Haideri continued her impressive trajectory, completing a postdoctoral fellowship at North Shore University Hospital, Manhasset, New York (1987-1988), followed by research positions at Long Island Jewish Medical Center (1988-1990) and Albert Einstein College of Medicine, Bronx, New York (1989-1991). During this time, she held the title of Instructor of Immunology, Rheumatology, and Allergy. Dr. Al-Haideri’s academic and research career reached new heights when she joined Columbia University’s College of Physicians and Surgeons, where she worked as an NIH Postdoctoral Research Trainee (1991-1994), eventually becoming an Associate Research Scientist and Assistant Professor (1994-2004).

Contributions and Research Focus 🔬

Dr. Al-Haideri’s research has primarily focused on clinical pathology, immunology, rheumatology, and allergy. Her work has been instrumental in enhancing the understanding of immunological responses in various pathological conditions. She has been actively involved in numerous research projects, often collaborating with leading medical institutions in both the U.S. and Iraq.

Her role as Director of Quality Control and Standardization in Iraq’s Ministry of Health laid the groundwork for the development of national policies aimed at ensuring the accuracy and reliability of clinical laboratory diagnostics across the country. In the U.S., her work at prestigious institutions like Columbia University and Albert Einstein College of Medicine helped advance the field of immunology, particularly in relation to autoimmune diseases.

Accolades and Recognition 🏆

Dr. Al-Haideri’s work has been widely recognized through various awards and honors. She received NIH Grant Awards from 1991 to 1994, which supported her groundbreaking research in immunology and pathology. Her academic excellence was also acknowledged at Columbia University, where she was awarded Graduate Research Assistantships.

Her commitment to medical education and healthcare development in Iraq earned her numerous accolades, including being named Employee of the Year at Hawler Medical University in Erbil, Kurdistan in 2012. Additionally, she received letters of appreciation from the Minister of Higher Education and Scientific Research in the Kurdistan region, as well as from the President of Hawler Medical University and several deans of colleges at the university for her contributions to education and healthcare.

Impact and Influence 🌍

Dr. Al-Haideri has had a profound impact on medical education and healthcare both in Iraq and abroad. As a leader in various institutions, she has played a critical role in shaping the medical education system in the Kurdistan Region of Iraq. Her tenure as Dean of the College of Health Sciences at Hawler Medical University (2014-2018) and Director of Quality Assurance (2010-2015) helped set new standards for academic excellence and institutional leadership in the region.

Her influence extends beyond academia. Dr. Al-Haideri has been an active member of numerous professional societies, including the American Society for Biochemistry and Molecular Biology and the American Heart Association, further cementing her status as a respected expert in her field. Her involvement in international organizations, such as the International Institute of Education in New York, reflects her commitment to global collaboration and knowledge exchange.

Legacy and Future Contributions 🔮

Dr. Maysoon Tahir Al-Haideri’s legacy is one of dedication to advancing medical knowledge, improving healthcare systems, and fostering academic excellence. Her work has had a lasting impact on the clinical and academic landscapes in Iraq, particularly in the Kurdistan region, where she has influenced generations of healthcare professionals through her leadership roles at Hawler Medical University and Cihan University-Erbil.

As she continues her work as the Director of the Pharmacy Program at the University of Kurdistan Hewler, Dr. Al-Haideri remains committed to mentoring students and contributing to the development of the healthcare sector in the region. Her achievements serve as an inspiration to future generations of scientists, educators, and healthcare professionals, ensuring her legacy will endure for years to come.

🎓Publication 

Silymarin suppresses proliferation and PD-L1 expression in colorectal cancer cells and increases inflammatory CD8+ cells in tumor-bearing mice

  • Authors   :Al-Haideri, M.
  • Journal    :Clinics and Research in Hepatology and Gastroenterology
  • Year         :2024

Functional and financial analysis of an inclined step solar desalination using phase change nanomaterials

  • Authors   : Mahal, A., Al-Haideri, M., Alkhouri, A., Obaidullah, A.J., Duan, M.
  • Journal    :Water Science and Technology
  • Year         :2024

Tuning the optoelectronic properties of selenophene-diketopyrrolopyrrole-based non-fullerene acceptor to obtain efficient organic solar cells through end-capped modification

  • Authors   :Ijaz, R., Waqas, M., Mahal, A., … Alatawi, N.S., Aloui, Z.
  • Journal    :Journal of Molecular Graphics and Modelling,
  • Year         :2024

Rational designing of phenothiazine dioxide based hole transporting materials for efficient perovskite solar cells

  • Authors   : Hanan, M., Umair, Mahal, A., … Farooq, Z., Mahr, M.S.
  • Journal    : Solar Energy,
  • Year         :2024

Linking the increasing epidemiology of scrub typhus transmission in India and South Asia: are the varying environment and the reservoir animals the factors behind?

  • Authors   : Mohapatra, R.K., Al-Haideri, M., Mishra, S., … Mohanty, A., Sah, R.
  • Journal    :Frontiers in Tropical Diseases,
  • Year         :2024

Dr. S.K. Geetha|Pharmaceutical Analysis|Best Researcher Award

Published on by Top Pharmaceutical

Dr. S.K. Geetha|Pharmaceutical Analysis |Best Researcher Award

Dr. S.K. Geetha at Government Arts College, Nandanam,India

PROFILE  

scopu

 Google scholar

 

Early Academic Pursuits 🎓

Dr. S.K. Geetha’s journey in the field of physics began with her foundational studies in Chennai. She obtained her M.Sc. in Physics from Queen Mary’s College (QMC), Chennai, and further pursued her M.Phil. in Physics at Madras Christian College (MCC), Tambaram. These prestigious institutions set the stage for her illustrious academic career. Her thirst for knowledge and a passion for research led her to complete her Ph.D. in Physics at Anna University, Chennai. Specializing in advanced research areas, she began honing her expertise, ready to contribute meaningfully to the field of physics both as an educator and researcher.

Professional Endeavors 🏫

Dr. Geetha’s teaching career spans an impressive 28 years at the undergraduate (UG) level and 15 years at the postgraduate (PG) level. She is currently an Associate Professor in the PG & Research Department of Physics at the Government Arts College for Men (Autonomous), Nandanam, Chennai, affiliated with Madras University. Her tenure has been characterized by dedication to both her students and the academic community.

Her pedagogical expertise is vast and covers a wide range of subjects. At the PG level, she has taught courses such as Statistical Mechanics, Condensed Matter Physics, Electromagnetic Theory, and Material Science, to name a few. For UG students, she has imparted knowledge in subjects like Basic Electronics, Mechanics, Quantum Mechanics, and Acoustics, ensuring a comprehensive understanding of fundamental and advanced physics concepts. Her commitment to preparing students for competitive exams such as CSIR-NET and PG TRB exams demonstrates her dedication to student success.

Research Focus and Contributions 🔬

Dr. Geetha’s research interests are diverse, encompassing a broad spectrum of physics topics. She has an impressive 27 years of research experience, guiding students at the M.Phil. and Ph.D. levels. Since being awarded Ph.D. guideship in 2015, she has successfully mentored one student who has been awarded a doctorate, while four others are currently pursuing their Ph.D. under her supervision.

Her contributions to physics research are further demonstrated through her editorial board membership in the International Journal of Materials Science and Application (IJMSA). Dr. Geetha has published significant work, including a noteworthy presentation titled “A Comparative, Experimental, Theoretical Study (DFT/B3LYP) of Antidepressant Drug Beta – Methyl Imipramine,” which was presented at the National Conference on Functional Materials and Its Application Aspects (NCFMAA-2022).

In addition to her research, Dr. Geetha is the author of the Tamil Nadu State Board Science Book (Physics) for Class 9, making an essential contribution to education at the school level. Her involvement in entrance coaching for CSIR-NET and other competitive exams further underscores her commitment to physics education.

Accolades and Recognition 🏆

Dr. Geetha’s excellence in teaching and research has not gone unnoticed. She was the recipient of the Best Teacher Award for the Year 2005-2006 at Meenakshi College of Engineering, Chennai. Her dedication to her students has also been recognized with a Certificate of Appreciation for producing a remarkable 92% result at Rajiv Gandhi College of Engineering. Dr. Geetha’s hard work and dedication earned her the confidence of the management, who appointed her to the Administrative Committee of Rajiv Gandhi College of Engineering.

Her services to the academic community were further acknowledged when she received a Certificate of Honour for her contributions to her college in 1992-1993. More recently, she was entrusted with TRB Confidential Work in October 2021, which speaks to the trust placed in her by the educational authorities. Her contributions have been further recognized with a Certificate of Merit for her paper presentation at NCFMAA-2022.

Impact and Influence 🌍

Dr. Geetha’s influence extends beyond the classroom and research labs. As a teacher, she has shaped the academic lives of countless students, fostering critical thinking, scientific curiosity, and a passion for physics. Her contribution to competitive exam coaching has empowered students to pursue advanced studies and careers in physics, elevating their academic pursuits.

Her editorial work with the International Journal of Materials Science and Application (IJMSA) reflects her commitment to fostering a platform for the dissemination of cutting-edge research. Dr. Geetha’s research, particularly in the field of antidepressant drug studies, continues to contribute valuable insights to both the academic and scientific communities.

Legacy and Future Contributions 🌱

Dr. S.K. Geetha’s legacy is one of dedication, academic excellence, and a tireless pursuit of knowledge. Her contributions to the field of physics, both as a teacher and researcher, have left an indelible mark on her students and colleagues alike. As a guide to future generations of physicists, her impact will continue to ripple through the academic community.

Moving forward, Dr. Geetha is poised to continue her research and mentorship roles, guiding more students through the rigors of academic research in physics. Her work on physics education, particularly through textbook authorship and curriculum development, will continue to influence young minds and contribute to the academic success of students across Tamil Nadu.

Conclusion 🎉

Dr. S.K. Geetha’s academic journey, professional accomplishments, and unwavering dedication to the field of physics have positioned her as a leading figure in physics education and research. Her legacy is defined by her contributions to academia, her influence on her students, and her continuous pursuit of knowledge. Dr. Geetha’s career is a testament to the impact a dedicated educator and researcher can have on the academic and scientific community, and her future contributions will no doubt further this legacy.

🎓Publication 

Habit modification and improvement in properties of potassium hydrogen phthalate (KAP) crystals doped with metal ions

  • Authors   :SK Geetha, R Perumal, S Moorthy Babu, PM Anbarasan
  • Journal    :Crystal Research and Technology: Journal of Experimental and Industrial Crystallography
  • Year         :2006

Computational investigation, comparative approaches, molecular structural, vibrational spectral, non-covalent interaction (NCI), and electron excitations analysis of …

  • Authors   :S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    :Journal of Molecular Modeling
  • Year         :2021

Theoretical investigation on influence of protic and aprotic solvents effect and structural (Monomer, Dimer), Van-der Waals and Hirshfeld surface analysis for clonidine molecule

  • Authors   : S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    : Computational and Theoretical Chemistry
  • Year         :2021

Vibrational spectra and Wavefunction investigation for antidepressant drug of Amoxapine based on quantum computational studies

  •  Authors   : S Sarala, SK Geetha, S Muthu, Fazilath Basha Asif
  • Journal    :Chemical Data Collections
  • Year         :2021

Probing solvent effect and strong and weak interactions in 2-Nitrophenyl-hydrazine using independent gradient model and Hirshfeld from wave function calculation

  • Authors   : S Sarala, SK Geetha, S Muthu, Ahmad Irfan
  • Journal    :  Molecular Liquids
  • Year         :2021

Prof. Rasha Azzam|Drug Discovery and Development|Best Researcher Award

Published on by Top Pharmaceutical

Prof. Rasha Azzam|Drug Discovery and Development |Best Researcher Award

Prof. Rasha Azzam at Helwan University,Egypt

PROFILE  

orcid

Early Academic Pursuits 🎓

Prof. Rasha A. Azzam’s academic journey began with her outstanding performance in chemistry at Helwan University, Egypt, where she graduated with a Bachelor of Science (B.Sc.) in Chemistry in 1993. Her excellence in academia was recognized early on, as she graduated with class honors and was placed on the Dean’s List. Driven by her passion for organic chemistry, she pursued a Master of Science (M.Sc.) degree in Organic Chemistry at Helwan University, completing it in 1996. Her academic curiosity and dedication led her to further her studies internationally, earning a prestigious Ph.D. in Organic Chemistry in 2003 from the Catholic University of Leuven in Belgium. Her diverse educational background laid the foundation for a career defined by groundbreaking research and academic excellence.

Professional Endeavors 🧑‍🔬

Prof. Azzam’s professional career spans over two decades of teaching, research, and leadership in various prestigious academic institutions across the globe. She is currently a Professor of Organic Chemistry at the Faculty of Science, Helwan University, where she has been contributing since 2021. Prior to this, she held the position of Associate Professor of Organic Chemistry at the same institution from 2016 to 2021, demonstrating her upward trajectory in academia.

Her teaching and research influence extended beyond Egypt. She has held positions as an Associate Professor at Taibah University in Saudi Arabia, Nigerian Turkish Nile University in Nigeria, and the American University in Nigeria, where she was a co-founder of the Petroleum Chemistry Program. Additionally, she has served as a Visiting Professor at Virginia Commonwealth University in 2024, further showcasing her international academic reach.

Contributions and Research Focus 🔬

Prof. Azzam’s research focuses on organic and medicinal chemistry, with a particular emphasis on green synthesis, nanomaterials, and antiviral agents. One of her key research interests is the development of new methods for synthesizing compounds with potential anticancer and antimicrobial properties. Her recent project, “Synthesis of new sulfa derivatives under ultrasonic irradiation as potential anticancer/antimicrobial agents,” funded by Helwan University in 2021, highlights her innovative approach to organic synthesis.

Prof. Azzam’s work also explores environmentally friendly technologies, as demonstrated by her research on “green technology based on nanoporous biodegradable polymeric membranes” for wastewater treatment, funded by the Academy of Scientific Research Technology (ASRT). She has also conducted pioneering work on nanomaterials and their applications in industrial processes, such as her research on thermoplastic elastomers based on petrochemicals and the development of anti-COVID-19 agents incorporated into nanofibrous mats.

Her research output is extensive, and she has presented several projects on global platforms, including her work on antiviral therapeutic agents and nanomaterials. Her research contributions are shaping the future of organic chemistry, particularly in the domains of green chemistry and medical applications.

Accolades and Recognition 🏆

Prof. Azzam’s excellence in research and community service has been recognized through numerous awards and honors. In 2023, she received the prestigious Prince Mohammed Bin Fahd Scientific Award for her contributions to scientific production that serves community development within the framework of sustainable development goals. In the same year, she was honored with Helwan University’s Outstanding Scientific Achievement Award in Basic and Applied Sciences.

She has also been recognized for her mentoring and supervision of students, receiving Best Master Thesis Awards for two of her master’s students, Rasha Essam (2020) and Heba Elboshi (2023). Her commitment to advancing research was further acknowledged when she received the Research Excellence Awards for her students, Rokia Ramadan (2019) and Rasha Essam (2020). Additionally, Prof. Azzam was awarded a Silver Medal from the Academy of Scientific Research Technology (ASRT) in 2018 for her outstanding contributions to science.

Her impact extends internationally, with her receiving the Outstanding Faculty Member Award from the American University in Nigeria in 2007, and a research scholarship from the Catholic University of Leuven in 2001.

Impact and Influence 🌍

Prof. Azzam’s influence is felt not only through her research but also through her active participation in the scientific community. She serves as a Review Editor for Organic Chemistry on the Editorial Board of Frontiers in Chemistry and as an editor for the Journal of Chemistry and The Scientific World Journal, both published by Hindawi. She is also a grant evaluator for the Fulbright Binational Scholarship Program, where she helps assess the next generation of academic leaders.

Her commitment to education and community service is reflected in her involvement in organizing training workshops for high school teachers and instructing lab sessions for the AUN Community School. Prof. Azzam is also a member of the Egyptian Society for Basic Sciences, where she contributes to the development of the scientific community in Egypt.

Legacy and Future Contributions 🌟

Prof. Rasha A. Azzam’s legacy is built on her unwavering dedication to advancing organic chemistry, fostering academic excellence, and mentoring the next generation of scientists. Her research has laid the groundwork for significant developments in green chemistry, nanomaterials, and medicinal chemistry. With her continued focus on innovative solutions for pressing global challenges, such as wastewater treatment and the development of antiviral agents, she is poised to make even more impactful contributions in the years to come.

🎓Publication 

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

  • Authors   :Toka I. Ismail; Nashwa El-Khazragy; Rasha A. Azzam
  • Journal    :RSC Advances
  • Year         :2024

Novel High-Performance Functionalized and Grafted Bio-Based Chitosan Adsorbents for the Efficient and Selective Removal of Toxic Heavy Metals from Contaminated Water

  • Authors   :Mohammad Monir; Rasha E. Elsayed; Rasha Azzam; Tarek M. Madkour
  • Journal    :Polymers
  • Year         :2024

Crystal structure of 4-(benzo[d]thiazol-2-yl)-1,2-dimethyl-1H-pyrazol-3(2H)-one

  • Authors   :Heba A. Elboshi; Rasha A. Azzam; Galal H. Elgemeie; Peter G. Jones
  • Journal    :Acta Crystallographica Section E Crystallographic Communications
  • Year         :2024

Synthesis of New Guanidine Benzothiazole Derivative and Its Application as Eco-Friendly Corrosion Inhibitor

  • Authors   : Abdel-karim, Amal M.; Azzam, Rasha A.; Shehata, Omnia S.; Adly, Mohamed A.; El-Shamy, Omnia A. A.; El-Mahdy, Gamal A.
  • Journal    :Chemistry
  • Year         :2023

Crystal structure of 2-{[5-(methylsulfanyl)-4-phenyl-4H-1,2,4-triazol-3-yl]methyl}benzo[d]thiazole

  • Authors   : Rasha A. Azzam; Galal H. Elgemeie; Heba A. Elboshi; Peter G. Jones
  • Journal    :Crystallographica Section E Crystallographic Communications
  • Year         :2023

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Ali Shayanfar|Pharmaceutical Chemistry |Best Researcher Award|

Prof Dr. Ali Shayanfar at abriz University of Medical Sciences, Iran

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Shayan Fara began his academic journey at the Faculty of Pharmacy, Tabriz University of Medical Sciences, where he earned his Pharm.D. from 2003 to 2009. During these formative years, he developed a strong foundation in pharmaceutical sciences, laying the groundwork for his future career. His passion for pharmaceutical chemistry drove him to pursue a Ph.D. in the same field at Tabriz University of Medical Sciences from 2009 to 2013. His doctoral research focused on the solid-state and solution chemistry of drugs, an area that would later become a central theme of his research.

Professional Endeavors and Career Growth 🏢

After completing his Ph.D., Dr. Fara joined the Faculty of Pharmacy at Tabriz University of Medical Sciences as an Assistant Professor of Pharmaceutical Chemistry in 2014. His dedication to teaching and research led to a steady rise in his academic career. By 2018, he had been promoted to Associate Professor, and in 2023, he reached the pinnacle of his academic career by becoming a full Professor of Pharmaceutical Chemistry.

Dr. Fara’s professional endeavors extend beyond teaching. He has held several key administrative positions, including serving as the Secretary and Research Secretary of the Student Research Committee at Tabriz University of Medical Sciences. His leadership skills and commitment to research were further recognized when he became the Head of the Student Research Committee from 2018 to 2020.

Contributions and Research Focus 🧪

Dr. Fara’s research interests are diverse and impactful, focusing on the solid-state and solution chemistry of drugs, pharmaceutical and biomedical analysis, and modeling in pharmaceutical sciences. He has made significant contributions to understanding the physical and chemical properties of drugs in both solid and solution states. His work in this area has implications for drug formulation, stability, and bioavailability, making it crucial for the development of more effective pharmaceutical products.

His expertise extends to various analytical techniques, including UV-Vis spectrophotometry, HPLC, spectrofluorimetry, FT-IR, DSC, and PXRD. He has also conducted extensive research in chemometrics, molecular modeling, QSAR and QSPR studies, solubility and dissolution rate determination techniques, and crystallization of drugs. His technical prowess in these areas has enabled him to contribute to the advancement of pharmaceutical sciences, both in theory and practice.

Accolades and Recognition 🏆

Throughout his career, Dr. Fara has received numerous accolades and recognition for his contributions to pharmaceutical sciences. His role as an editor in several prestigious journals, including being the Editor-in-Chief of the Pharmaceutical Sciences Journal since 2020, highlights his influence in the field. He has also served as an Associate Editor for the Pharmaceutical Sciences Journal from 2014 to 2020 and for the Directory of Open Access Journals (DOAJ) from 2017 to 2018.

His editorial roles, combined with his contributions to research, have earned him a place on the editorial boards of several high-impact journals, including Pharmaceutical Sciences and ImmunoAnalysis. His involvement with these journals not only showcases his expertise but also his commitment to advancing the quality and accessibility of scientific knowledge.

Impact and Influence 🌍

Dr. Fara’s impact on the field of pharmaceutical sciences is profound. His research has influenced the development of new analytical methods and drug formulations, contributing to the broader field of pharmaceutical chemistry. His work in modeling and chemometrics has provided valuable insights into the relationship between drug properties and their therapeutic efficacy.

In addition to his research contributions, Dr. Fara has been instrumental in mentoring the next generation of pharmaceutical scientists. His teaching experience spans various subjects, including Analytical Chemistry, Medicinal Chemistry, Instrumental Analysis, General Chemistry, Medical Information Systems, Research Methods, Endnote Software, and Ethics in Publication. His dedication to education ensures that his influence will extend far beyond his direct contributions to research.

Legacy and Future Contributions 🌟

As Dr. Fara continues his career as a Professor of Pharmaceutical Chemistry, his legacy is already being built through his research, teaching, and editorial work. His ongoing contributions to the field, particularly in the areas of drug analysis and modeling, will continue to shape the future of pharmaceutical sciences. His commitment to excellence in research and education, combined with his leadership in various academic and editorial roles, ensures that his impact will be felt for years to come.

🎓Publication 

Solubility of carvedilol in ethanol+ propylene glycol mixtures at various temperatures

  • Authors   :Sahel Vahdati, Ali Shayanfar, Jalal Hanaee, Fleming Martínez, William E Acree Jr, Abolghasem JouybanA et al...
  • Journal    :Industrial & Engineering Chemistry Research
  • Year         :2013

Review of pharmaceutical applications of N-methyl-2-pyrrolidone

  • Authors   :Abolghasem Jouyban, Mohammad Amin Abolghasemi Fakhree, Ali Shayanfar
  • Journal    :Journal of Pharmacy & Pharmaceutical Sciences
  • Year         :2010

Deep eutectic solvents for pharmaceutical formulation and drug delivery applications

  • Authors   :Shahram Emami, Ali Shayanfar
  • Journal    :Pharmaceutical development and technology
  • Year         :2020

Effect of choline chloride/ethylene glycol or glycerol as deep eutectic solvents on the solubility and thermodynamic properties of acetaminophen

  • Authors   : Hemayat Shekaari, Mohammed Taghi Zafarani-Moattar, Ali Shayanfar, Masumeh Mokhtarpour
  • Journal    :Journal of Molecular Liquids
  • Year         :2018

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

  • Authors   :Ommoleila Molavi, Farzaneh Narimani, Farshid Asiaee, Simin Sharifi, Vahideh Tarhriz, Ali Shayanfar, Mohammadsaied Hejazi, Raymond Lai
  • Journal    : Pharmaceutical biology
  • Year         :2017